2. Academic Validation
  3. NSUN2-tRNAVal-CAC-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression

NSUN2-tRNAVal-CAC-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression

  • Cell Mol Biol Lett. 2025 Aug 25;30(1):100. doi: 10.1186/s11658-025-00781-z.
Wenlong Wang # 1 2 3,  Ying Ding # 4,  Haixi Zhao 5,  Shouman Wang 6,  Juan Huang 7 8 9,  Lunquan Sun 10 11 12
Affiliations

Affiliations

  • 1 Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • 2 Clinical Research Center for Breast Cancer in Hunan Province, Changsha, 410008, China.
  • 3 Institute of Cancer Research, National Clinical Research Center for Geriatric Disorders (Xiangya), Xiangya Hospital, Central South University, Changsha, 410008, China.
  • 4 Department of Breast Thyroid Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
  • 5 College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
  • 6 Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China. wangshouman@126.com.
  • 7 Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China. 404369@csu.edu.cn.
  • 8 Clinical Research Center for Breast Cancer in Hunan Province, Changsha, 410008, China. 404369@csu.edu.cn.
  • 9 Multidisciplinary Breast Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. 404369@csu.edu.cn.
  • 10 Institute of Cancer Research, National Clinical Research Center for Geriatric Disorders (Xiangya), Xiangya Hospital, Central South University, Changsha, 410008, China. lunquansun@csu.edu.cn.
  • 11 Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. lunquansun@csu.edu.cn.
  • 12 Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. lunquansun@csu.edu.cn.
  • # Contributed equally.
PMID: 40855521 DOI: 10.1186/s11658-025-00781-z
Abstract

Background: Epitranscriptomic data indicate that aberrant tRNA modifications in malignant diseases can promote tumor growth by facilitating oncogene translation. NSUN2, a 5-methylcytosine (m5C) methyltransferase of tRNA, is elevated in an array of solid cancers, including triple-negative breast Cancer (TNBC). However, it remains unclear how NSUN2 drives aggressive behavior and if NSUN2 could be an effective therapeutic target for TNBC.

Methods: Functional experiments, including RNA interference, lentivirus transduction, and in vivo xenograft models, were conducted to evaluate the role of NSUN2 in TNBC cell proliferation, metastasis, and chemoresistance. Ribosome Sequencing (Ribo-seq), tRNA m5C bisulfite Sequencing, and codon usage bias analysis were employed to explore the translational mechanisms underlying NSUN2-mediated tRNA modifications. Glycolysis assays and molecular docking were used to investigate metabolic reprogramming and protein interactions.

Results: NSUN2 was significantly upregulated in TNBC and correlated with poor patient prognosis. Mechanistically, NSUN2 mediates m5C modification of tRNAVal-CAC, enhancing the codon-frequency-dependent translation of key glycolysis-related genes, including ALDH3A2, ALDH7A1, HK1, and PFKM. Depletion of NSUN2 disrupted tRNAVal-CAC m5C modification, impairing the translation of these metabolic Enzymes and suppressing glycolysis, which ultimately inhibited TNBC cell proliferation, migration, and invasion both in vitro and in vivo. Furthermore, NSUN2 overexpression conferred resistance to docetaxel, while its inhibition sensitized TNBC cells to docetaxel treatment. Clinically, elevated expression levels of NSUN2 and glycolysis-related genes were observed in docetaxel-resistant TNBC tissues, further supporting the role of NSUN2 in chemoresistance.

Conclusions: This study identifies NSUN2 as a critical regulator of TNBC progression through tRNAVal-CAC m5C modification and codon-biased translation of glycolysis-related mRNAs. Our findings reveal a novel NSUN2-tRNAVal-CAC axis that orchestrates metabolic reprogramming and translational control in TNBC, offering a promising prognostic biomarker and therapeutic target.

Keywords

Metabolism reprogramming; NSUN2; Triple-negative breast cancer; m5C modification; tRNA.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z